Transforming the path for equitable access to rapid diagnostics for epidemics
Mologic is a leading developer of lateral flow and rapid diagnostic technologies, products and services. Mologic works with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care.

Co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test. Launched in 1988, it was the world’s first commercial application of lateral flow technology.

The creativity, insight and knowledge that led to that ground breaking invention has guided Mologic since their formation in 2003, and they’ve been behind some of the most important innovations in rapid point-of-care diagnosis since then.

Mologic offers an extensive portfolio of device and reagent products for clinical and commercial applications along with world-leading scientific research expertise for your contract R&D requirements.

With their help, you can scale up manufacture from initial prototyping through low- to mid-scale production.

Whatever stage your point-of-care diagnostic product is at, they can help move it to the next level and beyond.
Date: 2 March 2021, 12:00 (Tuesday, 7th week, Hilary 2021)
Venue: Zoom
Speaker: Joe Fitchett (Mologics)
Organising department: Medical Sciences Office
Organisers: Elodie Siney (BioEscalator), Sheena Lee (MSD Business Partnerships Office), Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address: sheena.lee@medsci.ox.ac.uk
Hosts: Elodie Siney (BioEscalator), Sheena Lee (MSD Business Partnerships Office)
Part of: Industry Insight Seminar Series
Booking required?: Required
Booking url: https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost: Free
Audience: Members of the University of Oxford and the Biotech/Pharma industry
Editor: Sheena Lee